Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
Christopher R. Smith,Ruth Aranda,Thomas P. Bobinski,David M. Briere,Aaron C. Burns,James G. Christensen,Jeffery Clarine,Lars D. Engstrom,Robin J. Gunn,Anthony Ivetac,Ronald Jean-Baptiste,John M. Ketcham,Masakazu Kobayashi,Jon Kuehler,Svitlana Kulyk,J. David Lawson,Krystal Moya,Peter Olson,Lisa Rahbaek,Nicole C. Thomas,Xiaolun Wang,Laura M. Waters,Matthew A. Marx JOURNAL OF MEDICINAL CHEMISTRY（2022）
AI 理解论文
溯源树
样例
